Jing Huang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Jing Huang has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Yi Zhou
State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, Key Laboratory of Oral Biomedicine Ministry of Education, Hubei Key Laboratory of Stomatology, School & Hospital of Stomatology, Wuhan University, Wuhan, PR China, 430075.; Center for Prosthodontics and Implant Dentistry, Optics Valley Branch, School and Hospital of Stomatology, Wuhan University, Wuhan, PR China, 430223.
2 shared publications Donghua Guo
State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, Key Laboratory of Oral Biomedicine Ministry of Education, Hubei Key Laboratory of Stomatology, School & Hospital of Stomatology Wuhan University Wuhan China
1 shared publicationJuan Du
State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, Key Laboratory of Oral Biomedicine Ministry of Education, Hubei Key Laboratory of Stomatology, School & Hospital of Stomatology Wuhan University Wuhan China
1 shared publicationYaqi Cong
Department of Stomatology, Daping Hospital Army Medical University (The Third Military Medical University) Chongqing China
1 shared publication- Yining Wang
Advanced Imaging Research Center, UT Southwestern Medical Center, Dallas, TX, USA; Department of Biomedical Engineering, UT Southwestern Medical Center, Dallas, TX, USA
1 shared publication Yu Zhang
State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, Key Laboratory of Oral Biomedicine Ministry of Education, Hubei Key Laboratory of Stomatology, School & Hospital of Stomatology Wuhan University Wuhan China
1 shared publication
Latest Publications
- 17 June 2026
- Published by Wiley in Journal of Clinical Periodontology
METTL14 ‐Mediated m6A Modification of NEAT1_2 Releases YBX1 From Paraspeckles to Exacerbate Periodontitis
Aim: To investigate the role and epigenetic mechanism of methyltransferase 14 (METTL14)‐mediated N6‐adenylate methylation (m6A) modification of long non‐coding RNAs (lncRNAs) in the pathogenesis of periodontitis. Materials and Methods: A periodontal ligament–targeted Mettl14 ‐cKO mouse model ( Gli1‐Cre ERT2 ;Mettl14 fl/fl ) was established using silk ligatures. Human periodontal ligament cells (PDLCs) were used for in vitro assays. MeRIP‐seq, RNA‐seq, RNA pull‐down, mass spectrometry, RIP Co‐IP and CUT&Tag were performed to elucidate the METTL14–NEAT1_2–YBX1 axis. Results: METTL14 expression was significantly up‐regulated in inflamed periodontal tissue. METTL14 deficiency alleviated alveolar bone destruction and suppressed IL‐6 expression in vivo and in vitro. Mechanistically, METTL14 catalysed m6A modification of nuclear paraspeckle assembly transcript 1_2 (NEAT1_2), facilitating NEAT1_2 degradation. NEAT1_2‐organised paraspeckles (PSPs) sequestered the transcription factor Y‐box binding protein 1 (YBX1) under normal conditions. In periodontitis, METTL14‐induced NEAT1_2 down‐regulation triggered PSP disassembly, resulting in the translocation of YBX1 to the nucleus and increased IL‐6 transcription. Neat1_2 knockdown exacerbated bone loss and neutralised the protective effect of METTL14 deficiency. Conclusion: METTL14‐mediated m6A modification exacerbates periodontitis by disrupting NEAT1_2‐dependent PSP sequestration of YBX1. This study identifies the METTL14–NEAT1_2 axis as a critical regulator of periodontal inflammation, suggesting that METTL14 is a potential therapeutic target for periodontitis.
- 17 June 2026
- Published by Wiley in Journal of Clinical Periodontology
METTL14 ‐Mediated m6A Modification of NEAT1_2 Releases YBX1 From Paraspeckles to Exacerbate Periodontitis
Aim: To investigate the role and epigenetic mechanism of methyltransferase 14 (METTL14)‐mediated N6‐adenylate methylation (m6A) modification of long non‐coding RNAs (lncRNAs) in the pathogenesis of periodontitis. Materials and Methods: A periodontal ligament–targeted Mettl14 ‐cKO mouse model ( Gli1‐Cre ERT2 ;Mettl14 fl/fl ) was established using silk ligatures. Human periodontal ligament cells (PDLCs) were used for in vitro assays. MeRIP‐seq, RNA‐seq, RNA pull‐down, mass spectrometry, RIP Co‐IP and CUT&Tag were performed to elucidate the METTL14–NEAT1_2–YBX1 axis. Results: METTL14 expression was significantly up‐regulated in inflamed periodontal tissue. METTL14 deficiency alleviated alveolar bone destruction and suppressed IL‐6 expression in vivo and in vitro. Mechanistically, METTL14 catalysed m6A modification of nuclear paraspeckle assembly transcript 1_2 (NEAT1_2), facilitating NEAT1_2 degradation. NEAT1_2‐organised paraspeckles (PSPs) sequestered the transcription factor Y‐box binding protein 1 (YBX1) under normal conditions. In periodontitis, METTL14‐induced NEAT1_2 down‐regulation triggered PSP disassembly, resulting in the translocation of YBX1 to the nucleus and increased IL‐6 transcription. Neat1_2 knockdown exacerbated bone loss and neutralised the protective effect of METTL14 deficiency. Conclusion: METTL14‐mediated m6A modification exacerbates periodontitis by disrupting NEAT1_2‐dependent PSP sequestration of YBX1. This study identifies the METTL14–NEAT1_2 axis as a critical regulator of periodontal inflammation, suggesting that METTL14 is a potential therapeutic target for periodontitis.
- Open Access
- 7 April 2022
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 12 (18) , 11505-11516
Beneficial roles of the AhR ligand FICZ on the regenerative potentials of BMSCs and primed cartilage templates
Bone marrow-derived mesenchymal stem cells (BMSCs) are commonly used seed cells, and BMSC-derived primed cartilage templates have been shown to achieve bone regeneration in bone tissue engineering. Aryl hydrocarbon receptor (AhR) is a ligand-activated transcription factor involved in various cellular processes such as osteogenesis and immune regulation. This study investigated the effects of the AhR endogenous ligand 6-formyl (3,2-b) carbazole (FICZ) on the behavior of BMSCs and cartilage templates as well as the possible underlying molecular mechanisms. AhR expressions in rat bone marrow and isolated BMSCs were detected via immunohistochemistry (IHC) and immunofluorescent staining. Alkaline phosphatase staining and alizarin red staining showed that FICZ treatment enhanced the osteogenic potential of BMSCs without influencing their proliferation. FICZ was shown to alleviate the LPS-induced inflammatory cytokines IL-1β, 6 and TNF-α via the quantitative polymerase chain reaction (qPCR). In the chondrogenic process from BMSCs to primed cartilage templates, the expressions of AhR and its target gene cytochrome P450 subfamily B member 1 (CYP1B1) were inhibited. However, IHC staining demonstrated that AhR was still involved in the subcutaneous ossification of cartilage templates. Then, the effects of FICZ on cartilage templates were investigated. The osteogenic markers were upregulated by FICZ administration. The RAW 264.7 treated by condition medium of FICZ-treated cartilage templates exhibited an anti-inflammatory phenotype. Finally, high-throughput sequencing was applied to analyze the differentially expressed genes (DEGs) in the FICZ-treated cartilage templates. The upregulation of cytochrome P450 subfamily A member 1 (CYP1A1) and sphingomyelin phosphodiesterase 3 (Smpd3) were verified by qPCR, which might be the downstream targets of AhR in the cartilage templates promoting osteogenesis and macrophage polarization. These data implied a beneficial role of FICZ in the regenerative potentials of both BMSCs and primed cartilage templates. The FICZ/AhR axis might be a practical target to achieve optimal bone regeneration.
- 7 April 2022
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 12 (18) , 11505-11516
Open AccessBeneficial roles of the AhR ligand FICZ on the regenerative potentials of BMSCs and primed cartilage templates
Bone marrow-derived mesenchymal stem cells (BMSCs) are commonly used seed cells, and BMSC-derived primed cartilage templates have been shown to achieve bone regeneration in bone tissue engineering. Aryl hydrocarbon receptor (AhR) is a ligand-activated transcription factor involved in various cellular processes such as osteogenesis and immune regulation. This study investigated the effects of the AhR endogenous ligand 6-formyl (3,2-b) carbazole (FICZ) on the behavior of BMSCs and cartilage templates as well as the possible underlying molecular mechanisms. AhR expressions in rat bone marrow and isolated BMSCs were detected via immunohistochemistry (IHC) and immunofluorescent staining. Alkaline phosphatase staining and alizarin red staining showed that FICZ treatment enhanced the osteogenic potential of BMSCs without influencing their proliferation. FICZ was shown to alleviate the LPS-induced inflammatory cytokines IL-1β, 6 and TNF-α via the quantitative polymerase chain reaction (qPCR). In the chondrogenic process from BMSCs to primed cartilage templates, the expressions of AhR and its target gene cytochrome P450 subfamily B member 1 (CYP1B1) were inhibited. However, IHC staining demonstrated that AhR was still involved in the subcutaneous ossification of cartilage templates. Then, the effects of FICZ on cartilage templates were investigated. The osteogenic markers were upregulated by FICZ administration. The RAW 264.7 treated by condition medium of FICZ-treated cartilage templates exhibited an anti-inflammatory phenotype. Finally, high-throughput sequencing was applied to analyze the differentially expressed genes (DEGs) in the FICZ-treated cartilage templates. The upregulation of cytochrome P450 subfamily A member 1 (CYP1A1) and sphingomyelin phosphodiesterase 3 (Smpd3) were verified by qPCR, which might be the downstream targets of AhR in the cartilage templates promoting osteogenesis and macrophage polarization. These data implied a beneficial role of FICZ in the regenerative potentials of both BMSCs and primed cartilage templates. The FICZ/AhR axis might be a practical target to achieve optimal bone regeneration.